Role of Quantitative Electroencephalography, Neurotherapy, and Neuroplasticity in Recovery from Neurological and Psychiatric Disorders

Malkowicz, Denise E.; Martínez, Diana

doi:10.1080/10874200903127049

Cited by 7 publications

(5 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…More practice may improve neuroplasticity (Malkowicz & Martinez, 2009). Third, the pathophysiological mechanism of alpha asymmetry was not confirmed for all patients with MDD, even though there was higher alpha asymmetry score among patients with MDD than in the healthy controls (Debener et al, 2000;Kemp et al, 2010).…”

Section: Discussionmentioning

confidence: 99%

The efficacy of neurofeedback among patients with major depressive disorder: preliminary study

Wang¹,

Lin

Peper³

et al. 2016

View full text Add to dashboard Cite

Introduction: Alpha asymmetry of the left and right frontal hemisphere is a potential biomarker for major depressive disorder (MDD). Neurofeedback (NFB) is a clinical intervention program for regulating brain activity and decreasing alpha asymmetry. The purpose of this study was to explore the efficacy of NFB among patients with MDD. Methods: Fourteen patients with MDD were randomly assigned to a NFB group that received neurofeedback training 1 hr weekly for 6 weeks and to a control group that was treated without training. A 5-min resting baseline of electroencephalogram (EEG) was recorded at F3 (left) and F4 (right) before and after NFB, and the alpha power was analyzed as an asymmetry index (A1). Results: The A1 of the control group decreased from pre-to post-interventions while the A1 of the NFB group increased from pre-to post-interventions. Anxiety and depression scores of the responder group decreased from pre-to post-interventions, while the scores of the non-responder group increased from pre-to post-interventions. Conclusion: Patients who respond to the NFB training showed a decrease in anxiety and depression scores compared to those who do not. This study indicated that NFB could improve left frontal hypoarousal or right frontal hyperarousal among patients with MDD.

show abstract

Section: Discussionmentioning

confidence: 99%

The efficacy of neurofeedback among patients with major depressive disorder: preliminary study

Wang¹,

Lin

Peper³

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Studies using the general term of ‘sleep difficulties’ were not included and it would be interesting in the future to include these studies since favorable results with the use of NF were obtained. For example, NF was found to help reduce sleep difficulties in individuals that suffered from childhood obesity[ 67 ], seizures[ 68 ], fibromyalgia[ 69 ], stroke[ 70 ], traumatic brain injury[ 71 ], post-traumatic stress[ 71 ], etc . Second, our approach was a non-systematic one.…”

Section: Discussionmentioning

confidence: 99%

Neurofeedback for insomnia: Current state of research

Lambert-Beaudet

Journault

Provençal

et al. 2021

WJP

View full text Add to dashboard Cite

BACKGROUND Chronic insomnia affects about 6%-13% of the Canadian population. Although treatments already exist, they each have their own issues. Neurofeedback is a neuromodulation technique that specifically targets abnormal brain activity and is gaining attention as a possible insomnia treatment. AIM To review the latest studies pertaining to the use of neurofeedback in the treatment of insomnia. METHODS In this non-systematic review, only experimental studies assessing the effects of neurofeedback on patients with insomnia were targeted across four bibliographic databases. RESULTS A total of 12 studies were retained. All neurofeedback studies included in this study showed a clear improvement of subjective sleep. However, data concerning objective improvement are contradictory. Most studies regarding surface and z-score neurofeedback show that neurofeedback targeting the sensorimotor rhythm in the sensorimotor cortex may help improve subjective sleep. A placebo effect seems also to be present in some studies. Several limitations were present in each study. CONCLUSION While studies concerning neurofeedback as a treatment for insomnia are encouraging, many methodological barriers remain to be resolved to prove its efficacy unequivocally. More studies using robust design parameters, as well as the replication of existing studies, are necessary to support neurofeedback as an effective treatment for insomnia.

show abstract

“…Individualized NFB training has demonstrated the ability to decrease seizures and seizure-susceptibility (Cott et al, 1979), add clinical insight toward improving reported medication side effects (Legarda et al, 2011;Malkowicz & Martinez, 2009;Turner, 2021), and improve brain functioning correlated with improved quality of life in people with epilepsy (Morales-Quezada et al, 2019;Zhao et al, 2005). Documented seizure and EEG improvements have been replicated in numerous case studies and meta-analyses.…”

Section: Nfb For Seizures/epilepsy-current Evidencementioning

confidence: 99%

Biofeedback and Health Evidence-Based Biofeedback and Neurofeedback for People with Epilepsy and Seiz

Turner¹

2022

Policy Insights from the Behavioral and Brain Sciences

View full text Add to dashboard Cite

Epilepsy is the fourth most common neurological disorder worldwide despite many anti-seizure medications. Biofeedback (BFB) and neurofeedback (NFB) have shown significant promise since the 1960s to improve seizure control, abnormalities in electroencephalography (EEG) and quantitative-EEG, and quality of life. Epilepsy is a disease of brain networks and BFB/NFB is a non-invasive, brain-centered, low-risk, low-cost, and reliable treatment for people with seizures/epilepsy and especially since standard seizure medications and epilepsy surgery often do not result in complete seizure control. Neuroscience healthcare clinician experience and a 60-year literature foundation show that BFB/NFB to improve brain dysregulation and abnormal network dynamics are known to be at the root of seizures/epilepsy. BFB/NFB trains individuals to self-regulate brain activity through real-time performance feedback. An exhaustive literature review for NFB/BFB and seizures/epilepsy (1960s–present) yielded 150 articles documenting improvements in seizures and EEG/QEEG abnormalities. Clinicians, insurers, and the public should support BFB/NFB as a first-line intervention for seizures/epilepsy.

show abstract

Role of Quantitative Electroencephalography, Neurotherapy, and Neuroplasticity in Recovery from Neurological and Psychiatric Disorders

Cited by 7 publications

References 20 publications

The efficacy of neurofeedback among patients with major depressive disorder: preliminary study

The efficacy of neurofeedback among patients with major depressive disorder: preliminary study

Neurofeedback for insomnia: Current state of research

Biofeedback and Health Evidence-Based Biofeedback and Neurofeedback for People with Epilepsy and Seiz

Contact Info

Product

Resources

About